Concepedia

Dulanji Kuruppu

DK

Statistics

Publications

6

Citations

193

H-Index

6

Active since

2012

Affiliations

Eli Lilly (United States)(Current)

Indiana University – Purdue University Indianapolis

Indiana University School of Medicine

Dulanji Kuruppu is an author at Eli Lilly (United States) specializing in pharmacotherapy, headache management, and migraine pharmacotherapy.

Publications per year

2012–2022

6

Publications

6

Neuroprotective effects of testosterone on motoneuron and muscle morphology following spinal cord injury

James S. Byers, Anna L. Huguenard, Dulanji Kuruppu et al. · The Journal of Comparative Neurology · 2012 · 76 citations · Full text

, , +17

Longitudinal association between selenium levels and hypertension in a rural elderly Chinese cohort

Liqin Su, Yantao Jin, Frederick W. Unverzagt et al. · The journal of nutrition health & aging · 2016 · 34 citations · Full text

, , +16

Early onset of effect following galcanezumab treatment in patients with previous preventive medication failures

Todd J. Schwedt, Dulanji Kuruppu, Katherine Standley et al. · The Journal of Headache and Pain · 2021 · 28 citations · Full text

, , +13

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment

Miguel J. A. Láinez, Jean Schoenen, Chad Stroud et al. · Headache The Journal of Head and Face Pain · 2021 · 28 citations · Full text

, , +9

Does “wearing off” of efficacy occur in galcanezumab‐treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials

Jessica Ailani, Dulanji Kuruppu, Mallikarjuna Rettiganti et al. · Headache The Journal of Head and Face Pain · 2022 · 14 citations · Full text

, , +16

1–5 of 6